Equinox Group is skilled at conducting secondary research and analysis that enriches the results we deliver. We prepare case studies of analogs to draw learnings from the successes and failures of other products. We have strong command of a wide range of sources, from the epidemiologic and medical literature to clinical-trial and audit data. We are able to rapidly search out information about medical practice, drug development, and payer and policy issues that enhance our client projects.